Table.

Reported Cases of COVID-19 Related Anti-MOG Antibody-related Diseases.

References	Age	Gender	Symptom	Time relation between SARS-COV-2 infection and NP	Leision	Treatment	Response to treatment
(8)	4.17	M	Seizures, facial palsy,	NA	ADEM	High dose steroids	improvement
			four limb dysfunctions
(9)	15	M	Bilateral optic neuritis	Few weeks	ON	IVMP	Almost complete
							recovery
(10)	26	M	Eye pain, visual loss,	Few days	ON+myelitis	IVMP, oral	Visual acuity
			lower limb numbness			prednisolone	improved
(11)	44	M	Eye pain, loss of vision	2 weeks	ON	IVMP, orale	Improvement
						prednisolone
(12)	44	F	Dysphasia, weakness	7 days	CNS	IVMP, PE, oral	Improvement
			in right arm and leg			prednisolone
(13)	39	F	Eye pain, loss of vision	6 days	ON	IVMP, PE, oral	Partial
						prednisolone, MMF
(14)	11	M	Eye pain, loss of vision	4 days-2 weeks	ON	IVMP, oral	Improvement
						prednisolone
(15)	47	M	Eye pain, upper visual	2 days	ON	IVMP, oral	Partial
			field defect			prednisolone
(16)	63	M	Loss of vision,	4 weeks	ON	IVMP, oral	Improvement
			headache			prednisolone
(17)	7	F	Epilepsy, aphasia,	NA	CNS	IVIG	Improvement
			encephalopathy
			paralysis
(18)	31	M	Bladder and rectal	21 days	Myelitis	IVMP, oral	Improvement
			disorder, lower limbs			prednisolone
			pain
This case	22	M	Bladder and rectal	8 days	Myelitis	IVMP, PE, IVIG,	Improvement
			disorder, lower limbs			oral prednisolone
			dysfunctions

NA: not applicable, NP: neurological presentation, ADEM: acute disseminated encephalomyelitis, ON: optic neuritis, CNS: central nervous system, IVMP: intravenous methylprednisolone, IVIG: intravenous immunoglobulin, PE: plasma exchange, MMF: mycophenolate mofetil